Nirsevimab may offer infants stronger protection against severe respiratory syncytial virus than maternal vaccination, ...
NICE has recommended obinutuzumab with mycophenolate for severe lupus nephritis after trials showed higher renal response and fewer flares.
In patients who developed cutaneous immune-related adverse events, researchers compared outcomes for those who received ...
SurvivorNet on MSN
Cancer patients are living longer — a closer look at the treatments driving this progress
New data show cancer survival has reached a record high — nearly 70% of patients now live at least five years after diagnosis ...
Preliminary total global full year 2025 revenue of approximately $616 millionPreliminary BRIUMVI U.S. fourth quarter and full year 2025 net ...
Activation of the chemokine receptor CCR6 orchestrates the trafficking of IL-17-producing pathogenic immune cells to the sites of inflammation, thus contributing to the development of numerous ...
SaveHealth reports on common rheumatoid arthritis medications, highlighting their effectiveness, side effects, and cost management strategies.
Hosted on MSN
Antibody injections could replace slow IV drips in treating many diseases, MIT scientists find
Many patients endure hours-long infusions because antibody doses can exceed 100 milliliters, far beyond subcutaneous limits under 2 milliliters. Mike Johnson gives update on Jan. 6 plaque Two US ...
Incyte (Nasdaq:INCY) today announced positive topline results from the pivotal Phase 3 frontMIND trial evaluating the efficacy and safety of tafasitamab (Monjuvi ® /Minjuvi ®), a humanized Fc-modified ...
Lindsay Cook, PharmD, is a consultant pharmacist working with long-term care facilities. High doses of magnesium glycinate may cause diarrhea, gas, or stomach pain. Very high or long-term use can lead ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results